NCT03491683 2026-05-04INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)Inovio PharmaceuticalsPhase 1/2 Active not recruiting52 enrolled